1 2

The biotechnology sector of India is highly innovative and is on a strong growth trajectory. The sector, with its immense growth potential, will continue to play a significant role as an innovative manufacturing hub. The sector is one of the most significant sectors in enhancing India's global profile as well as contributing to the growth of the economy.

India is among the top 12 biotech destinations in the world and ranks third in the Asia-Pacific region. India has the second-highest number of US Food and Drug Administration (USFDA)–approved plants, after the USA and is the largest producer of recombinant Hepatitis B vaccine. Out of the top 10 biotech companies in India, seven have expertise in bio-pharmaceuticals and three specialise in agri-biotech.

India has no dearth of talent in biotechnology, as a number of institutions, both government and autonomous, provide the necessary opportunities for the students seeking to obtain a degree in this sector. The Government of India has provided adequate scope to this sector by providing facilities for Research and Development (R&D) in the field of biotechnology.

The Indian biotech industry holds about 2 per cent share of the global biotech industry. The biotechnology industry in India, comprising about 800 companies, is expected to be valued at US$ 11.6 billion in 2017. The government has to invest US$ 5 billion to develop human capital, infrastructure and research initiatives if it is to realise the dream of growing the sector into a US$ 100 billion industry by 2025.

Biopharma is the largest sector contributing about 62 per cent of the total revenue followed by bio-services (18 per cent), bio-agri (15 per cent), bio-industry (4 per cent), and bio-informatics contributing (1 per cent).

The high demand for different biotech products has also opened up scope for the foreign companies to set up base in India.

India has emerged as a leading destination for clinical trials, contract research and manufacturing activities owing to the growth in the bio-services sector.

Key Segments of Bio – Technology Industry

Bio-pharma

Bio-pharmaceutical products are therapeutic or preventative medicines that are derived from materials naturally present in living organisms, using recombinant DNA (rDNA) technology

Bio-services

Bio-services mainly include clinical research & CRO along with custom manufacturing

Bio-agri

Bio-agriculture is segmented into hybrid seeds, transgenic crops, biopesticides & biofertilisers

Bio-industrial

Bio-industrial predominantly comprises enzyme manufacturing & marketing companies

Bio-informatics

Bio-bioinformatics deals with the creation & maintenance of extensive electronic databases on various biological systems; industry

Major Products/services of Bio – Technology Industry

Bio-pharma

Vaccines, Diagnostic, Therapeutic

Bio-services

Contract Research Organisation, Custom Manufacturing, Clinical Trials

Bio-agri

Hybrid seeds, Bio-fertilizers, Bio-pesticides

Bio-industrial

Industrial enzymes

Bio-informatics

Database services, Integrated research app software, Biotech software services

1 2